The Hope Difference

here Hope-DifferenceTreating the whole person. Not only is it our mission, it’s what drives us every day. At Hope Cancer Care of Nevada, our patients receive the latest state-of-the-art cancer treatment along with a personally tailored program designed to put the body, mind and spirit at ease as it heals.

scalping method in forex trading Our philosophy, which combines leading medical treatments with the ability to focus solely on their recovery. This approach allows our highly trained staff to craft individualized treatment programs for each patient.

get link Patient dignity and respect is foremost at Hope Cancer Care of Nevada. We take great measures to exceed your expectations and to be there for you, and your family, every step of the way.

slide_0

Szent-Györgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller

02/15/18

http://mustangcipowebaruhaz.hu/?sisd=iq-option-metodi-di-pagamento&0d8=60 Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute will receive the 2018 Szent-Gyorgyi Prize for Progress in Cancer Research for the development of HPV vaccines. …read more Source:: Cancer


Highly Processed Foods & Cancer Risk

02/15/18

http://alsafeergate.com/arabu/252 By David Sampson A study out Wednesday suggests eating a lot of highly processed foods might be associated with higher rates of cancer. The study appears in BMJ, and the authors admit more study is needed, but warn that the … Read More


Rodents and Radiation: What to Take Away from New Study Findings

02/02/18

http://www.cottaemangiata.it/?kiolsaa=iq-trader-options&a07=a8 By David Sampson Preliminary data was released today from two rodent studies by the National Toxicology Program (NTP), to explore potential links between cell phones and cancer. The studies have found high exposure to radiofrequency radiation (RFR) resulted in tumors … Read More


Detecting cancer with a blood test: New study shows promise, but caution remains

01/19/18

By David Sampson A study published this week in Science reports promising results of a blood test designed to detect eight common cancer types by measuring circulating proteins and mutations in cell-free DNA. The study comes from the Johns Hopkins … Read More


Study links inflammation-causing foods to higher risk of colorectal cancer

01/18/18

By David Sampson A study in today’s JAMA Oncology links diets that include foods that can cause inflammation to an increased risk of colorectal cancer. Those foods include meats, refined grains, and high-calorie beverages. We asked Marji McCullough, SCD, RD, … Read More


Norman Sharpless sworn in as director of the National Cancer Institute

10/18/17

Norman E. “Ned” Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center. …read more … Read More


Behind the numbers: cancers associated with obesity

10/03/17

By David Sampson A report out today had a lot of us scratching our heads, when it said that about 630,000 people in the U.S. were diagnosed with a cancer associated with overweight and obesity in 2014. That sounds awfully … Read More


NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers

09/26/17

TMIST, the first randomized trial comparing two types of digital mammography for breast cancer screening, is enrolling participants. Developed by ECOG-ACRIN and NCI, the trial is comparing 2-D and 3-D mammography for finding breast cancers. …read more Source:: Cancer


NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

09/06/17

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines. …read more Source:: Cancer


New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

09/05/17

By David Sampson A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large … Read More